Sofosbuvir plus Velpatasvir plus Voxilaprevir in Daa Failure Patients with Cirrhosis. Final Results of the French Compassionate Use Program
Christophe Hezode
,
Dominique Guyader
,
Eric Nguyen-Khac
,
Dominique Larrey
,
Regine Truchi
et al.
Hepatology , 2018, 68 (1), pp.374A
Journal articles
hal-03590862v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts
Isabelle Ollivier-Hourmand
,
Yohann Repesse
,
Pierre Nahon
,
Cendrine Chaffaut
,
Thông Dao
et al.
Journal articles
hal-03553907v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Fabien Zoulim
,
Dominique Larrey
et al.
Journal articles
inserm-01057763v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Jean-Charles Duclos-Vallee
,
Christophe Duvoux
et al.
Hepatology , 2017, 66, pp.873A-874A
Journal articles
hal-01769634v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study
Sébastien Dharancy
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Christophe Duvoux
,
Nassim Kamar
et al.
Journal articles
hal-01640061v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference
Lina Mouna
,
Emilie Rossignol
,
Mariagrazia Tateo
,
Audrey Coilly
,
Jean-Charles Duclos-Vallee
et al.
Journal articles
hal-02120675v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study
Audrey Coilly
,
Claire Fougerou-Leurent
,
Victor De Ledinghen
,
Pauline Houssel-Debry
,
Christophe Duvoux
et al.
Journal articles
hal-01395132v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Epidemiological, clinical, biological and virological factors influencing the occurrence of hepatocellular carcinoma and validation of predictive scores in 317 HBV-related cirrhotic patients. Prospective study Cir-B nested in the ANRS CO12 CirVir cohort
Sepolene Brichler
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Hepatology , 2016, 63 (1 SUPP), pp.898A--899A
Journal articles
hal-01414692v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Impact of the New MELD-based Allocation System on Waiting List and Post-Transplant Survival - A Cohort Analysis Using the French National CRISTAL Database
Carine Jasseron
,
Claire Francoz
,
Corinne Antoine
,
Camille Legeai
,
François Durand
et al.
Journal articles
hal-02862291v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte Costentin
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-02648451v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Jean-Claude Trinchet
,
Valérie Bourcier
,
Cendrine Chaffaut
,
Mohand Ait Ahmed
,
Setty Allam
et al.
Journal articles
hal-01201948v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication
Manon Allaire
,
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
et al.
Journal articles
hal-02648452v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-02648450v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort)
Pierre Nahon
,
Mathilde Lescat
,
Richard Layese
,
Valérie Bourcier
,
Nabila Talmat
et al.
Journal articles
hal-01225507v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Nomogram for individualized prediction of hepatocellular carcinoma occurrence in hepatitis C virus cirrhosis (ANRS CO12 CirVir)
Nathalie Ganne-Carrié
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-01381662v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program
Christophe Hezode
,
Dominique Guyader
,
Eric Nguyen-Khac
,
Dominique Larrey
,
Regine Truchi
et al.
Journal articles
hal-03590860v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Patients with acute liver failure listed for superurgent liver transplantation in France: Reevaluation of the clichy-villejuif criteria
Philippe Ichai
,
Camille Legeai
,
Claire Francoz
,
Karim Boudjema
,
Olivier Boillot
et al.
Journal articles
hal-01150386v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Daclatasvir plus sofosbuvir with or without ribavirin in genotype 3 patients from a large French multicenter compassionate use program
Christophe Hézode
,
Victor De Ledinghen
,
Hélène Fontaine
,
Fabien Zoulim
,
Pascal Lebray
et al.
Journal articles
hal-01380169v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890
Christophe Hézode
,
Hélène Fontaine
,
Céline Dorival
,
Dominique Larrey
,
Fabien Zoulim
et al.
Journal articles
hal-01708037v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Nosocomial transmission of hepatitis B virus associated with endomyocardial biopsy
Michel Rosenheim
,
Jean-François Cadranel
,
Lieven Stuyver
,
Richard Dorent
,
Franck Golliot
et al.
Gastroentérologie Clinique et Biologique / Research and Clinics in Hepatology and Gastroenterology , 2006, 30 (11), pp.1274-80.
⟨10.1016/s0399-8320(06)73535-7⟩
Journal articles
hal-00465327v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Sofosbuvir and NS5A inhibitors without Ribavirin during 12 weeks are efficient to treat hepatitis C recurrence after liver transplantation only in genotype 1. Results from the CO23 ANRS CUPILT study.
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Hepatology , 2017, 63 (1 SUPP), pp.465A--465A
Journal articles
hal-01412958v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation
Pauline Houssel-Debry
,
Audrey Coilly
,
Claire Fougerou-Leurent
,
Caroline Jezequel
,
Christophe Duvoux
et al.
Journal articles
hal-01807755v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?
Lucy Meunier
,
Mohamed Belkacemi
,
George Philippe Pageaux
,
Sylvie Radenne
,
Anaïs Vallet-Pichard
et al.
Journal articles
hal-03980202v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
Etienne Audureau
,
Fabrice Carrat
,
Richard Layese
,
Carole Cagnot
,
Tarik Asselah
et al.
Journal articles
hal-03284519v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte Costentin
,
Richard Layese
,
Valérie Bourcier
,
Carole Cagnot
,
Patrick Marcellin
et al.
Journal articles
hal-04075104v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon
,
Valérie Bourcier
,
Richard Layese
,
Etienne Audureau
,
Carole Cagnot
et al.
Journal articles
hal-01447065v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More